Population
mice
Design
Preclinical
Authors
Loading...
May implicate TNF-α inhibition as AF therapeutic target; hypothesis-generating in mice and leaves clinical translation open.
TNF-α contributes to the development of an arrhythmogenic substrate and atrial fibrillation in mice through TGF-β signaling, myofibroblast activation, and MMP secretion.
Liew et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: